Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jul 27, 2022; 14(7): 670-684
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.670
Published online Jul 27, 2022. doi: 10.4240/wjgs.v14.i7.670
Figure 2 Overall survival and recurrence-free survival rates of patients with or without renal dysfunction.
A: Overall survival (OS) was similar between the renal dysfunction (RD) and non-RD groups (P = 0.524); B: OS was also similar among the severe, mild, and control groups (P = 0.605); C: Recurrence-free survival (RFS) was similar between the RD and non-RD groups (P = 0.464); D: RFS was also similar among the severe, mild, and control groups (P = 0.762). RD: Renal dysfunction.
- Citation: Sakamoto Y, Shimada S, Kamiyama T, Sugiyama K, Asahi Y, Nagatsu A, Orimo T, Kakisaka T, Kamachi H, Ito YM, Taketomi A. Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection. World J Gastrointest Surg 2022; 14(7): 670-684
- URL: https://www.wjgnet.com/1948-9366/full/v14/i7/670.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i7.670